Sandoz Group AG/Fr. SDZ
1D1W1MYTD1Y5YMAX
About Sandoz Group AG
Sandoz Group AG operates in the pharmaceutical industry and is primarily focused on the development, production, and marketing of generic pharmaceuticals and biosimilars. The company offers a wide range of products including antibiotics, dermatology treatments, and respiratory medicines. Sandoz initially began as an independent company and has a notable history as part of the larger Novartis group, from which it separated to re-establish its standalone position. Headquartered in Basel, Switzerland, Sandoz has a significant global presence in various key markets. The company's strategic positioning is bolstered by its extensive portfolio of generic and biosimilar medicines, allowing it to compete effectively within the cost-sensitive segments of the pharmaceutical market.
- Ticker
- Fr. SDZ
- Sector
- Health
- Primary listing
- XSWX
- Employees
- 20,000
- Headquarters
- Basel, Switzerland
- Website
- www.sandoz.com
Sandoz Group AG Metrics
BasicAdvanced
CHF 32B
62.48
CHF 1.17
0.49
CHF 0.80
1.09%
Price and volume
Market cap
CHF 32B
Beta
0.49
52-week high
CHF 75.90
52-week low
CHF 43.86
Average daily volume
869K
Dividend rate
CHF 0.80
Financial strength
Current ratio
1.054
Quick ratio
0.624
Long term debt to equity
52.794
Total debt to equity
68.915
Dividend payout ratio (TTM)
68.89%
Interest coverage (TTM)
5.02%
Profitability
EBITDA (TTM)
1,259.137
Gross margin (TTM)
47.94%
Net profit margin (TTM)
5.53%
Operating margin (TTM)
9.33%
Effective tax rate (TTM)
23.19%
Revenue per employee (TTM)
CHF 463,970
Management effectiveness
Return on assets (TTM)
3.07%
Return on equity (TTM)
7.25%
Valuation
Price to earnings (TTM)
62.48
Price to revenue (TTM)
3.406
Price to book
3.56
Price to tangible book (TTM)
-40.88
Price to free cash flow (TTM)
41.171
Free cash flow yield (TTM)
2.43%
Free cash flow per share (TTM)
1.783
Dividend yield (TTM)
1.09%
Forward dividend yield
1.09%
Growth
Revenue change (TTM)
10.29%
Earnings per share change (TTM)
180.85%
3-year revenue growth (CAGR)
6.89%
3-year earnings per share growth (CAGR)
0.99%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.